# FDA Warning Letter: Devalingam Mahalingam, M.D., Ph.D.
> 2025-12-30 · Center for Drug Evaluation and Research (CDER) · `3da9c18df4ef6eeb`
## Letter
- **Company:** Devalingam Mahalingam, M.D., Ph.D.
- **Posted Date:** 2025-12-30
- **Letter Issue Date:** 2025-12-11
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
Clinical Investigator
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*